SPRYCEL Side Effects

7009278-1 | Haemolytic Anaemia
on Sep 21, 2010 Female patient from SPAIN , 80 years of age, was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: haemolytic anaemia. Sprycel dosage: .

7007804-X | Ovarian Cancer
Patient was taking Sprycel (View Usage). Patient had the following side effects: ovarian cancer on Sep 21, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 72 years of age, weighting 154.3 lb, was diagnosed with chronic myeloid leukaemia, lymphoma (What is lymphoma?) and. Sprycel dosage: Alternate Days. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE SULFATE (View Vincristine Sulfate Review and Vincristine Sulfate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6992981-7 | Febrile Neutropenia, Hypersplenism, Malignant Neoplasm Progression, Pregnancy, Septic Shock
Adverse event was reported on Sep 09, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with leukaemia and. Location: BRAZIL , 30 years of age, After Sprycel was administered, patient had the following side effects: febrile neutropenia, hypersplenism, malignant neoplasm progression, pregnancy (What is pregnancy?), septic shock. During the same period patient was treated with ARACYTINE (View Aracytine Review and Aracytine Label ). Patient was hospitalized.

6992260-8 | Bladder Dilatation, Urinary Retention
on Sep 10, 2010 Male patient from FRANCE , 42 years of age, was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: bladder dilatation, urinary retention. Sprycel dosage: Started As 50mg In Sep-oct 2009 Then Took 100mg Jan-feb10. During the same period patient was treated with COLCHIMAX (View Colchimax Review and Colchimax Label ).


6992210-4 | Pleural Effusion, Sepsis, Thrombocytopenia, White Blood Cell Count Increased
on Sep 14, 2010 Female patient from UNITED STATES , 40 years of age, was treated with Sprycel (View Usage). Patient had the following side effects: pleural effusion, sepsis (What is sepsis?), thrombocytopenia, white blood cell count increased. Sprycel dosage: . During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), TASIGNA (View Tasigna Review and Tasigna Label ). Patient was hospitalized.

6984862-X | Abortion Spontaneous, Pregnancy
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?) on Sep 09, 2010 from BRAZIL Additional patient health information: Female patient , 30 years of age, was diagnosed with leukaemia and. Sprycel dosage: .

6983384-X | Hyperthyroidism, Thyroid Neoplasm
Adverse event was reported on Sep 08, 2010 by a Male patient taking Sprycel (View Usage) (Dosage: Since 1 Month) . Location: FRANCE , 37 years of age, Patient experienced the following unwanted or unexpected effects: hyperthyroidism, thyroid neoplasm. Patient was hospitalized.

6983377-2 | Abortion Spontaneous, Pregnancy
on Sep 09, 2010 Female patient from BRAZIL , 30 years of age, was diagnosed with leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). Sprycel dosage: Interrupted On Nov09. During the same period patient was treated with CLADRIBINE (Interrupted On Nov09) (View Cladribine Review and Cladribine Label ).

6973544-6 | Anaemia, Fatigue, Tendon Rupture
on Sep 03, 2010 Male patient from FRANCE , 67 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: anaemia, fatigue, tendon rupture. Sprycel dosage: Dose Reduced To 80mg. Patient was hospitalized.

6973501-X | Anaemia, Neutrophil Count Decreased, Platelet Count Decreased, Pleural Effusion, White Blood Cell Count Decreased
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, neutrophil count decreased, platelet count decreased, pleural effusion, white blood cell count decreased on Sep 03, 2010 from JAPAN Additional patient health information: Female patient , 39 years of age, weighting 119.0 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: Started-27feb09-25mar09;restarted-26mar09-10jun09. During the same period patient was treated with ENDOXAN (View Endoxan Review and Endoxan Label ), ENTECAVIR (Entecavir Hydrate;form Tabs) (View Entecavir Review and Entecavir Label ), IMATINIB MESYLATE (Form Tabs) (View Imatinib Mesylate Review and Imatinib Mesylate Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (Form Tabs) (View Prednisolone Review and Prednisolone Label ), LANSOPRAZOLE (Form Tabs) (View Lansoprazole Review and Lansoprazole Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (2 Df = 2tabs) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), LEVOFLOXACIN (Form Tabs;levofloxacin Hydrate) (View Levofloxacin Review and Levofloxacin Label ). Patient was hospitalized.

6970087-0 | Decreased Appetite, Dehydration, Dizziness, Nausea
Adverse event was reported on Aug 31, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: Interrupted 03jul10 (total Dose This Coures: 2100 Mg), Restarted 15jul10. Cyc=28days Course:1) was diagnosed with adenoid cystic carcinoma and. Location: UNITED STATES , 45 years of age, weighting 149.9 lb, Patient had the following side effects: decreased appetite, dehydration, dizziness (What is dizziness?), nausea (What is nausea?). Patient was hospitalized.

6955396-3 | Anaemia, Decreased Appetite, Dehydration, Diarrhoea, Gastrointestinal Disorder, Gastrointestinal Haemorrhage, Headache, Malignant Neoplasm Progression, Nausea
on Aug 20, 2010 Female patient from JAPAN , 68 years of age, weighting 103.6 lb, was diagnosed with acute lymphocytic leukaemia, infection prophylaxis, gastritis, neuropathy peripheral, reflux oesophagitis, hypertension and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: anaemia, decreased appetite, dehydration, diarrhoea, gastrointestinal disorder, gastrointestinal haemorrhage, headache (What is headache?), malignant neoplasm progression, nausea (What is nausea?). Sprycel dosage: 21apr09-17may09 50mg Bid,18may09-13jun0970mg Bid;24jun09-15aug09:50mg/d. During the same period patient was treated with IMATINIB MESYLATE (1 Df=tab, Took 300-600 Mg/day From 29-jan-09 To 20-feb-09) (View Imatinib Mesylate Review and Imatinib Mesylate Label ), POLYMYXIN B SULFATE (1dosageform=3tabs) (View Polymyxin-b-sulfate Review and Polymyxin-b-sulfate Label ), BIFIDOBACTERIUM BIFIDUM (Formulation=gran) (View Bifidobacterium Bifidum Review and Bifidobacterium Bifidum Label ), MOSAPRIDE CITRATE (Hydrate) (View Mosapride Citrate Review and Mosapride Citrate Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), OMEPRAZOLE (Tabs) (View Omeprazole Review and Omeprazole Label ), VALSARTAN (Tabs) (View Valsartan Review and Valsartan Label ), PROPRANOLOL HYDROCHLORIDE (Tabs) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ). Patient was hospitalized.

6942322-6 | Agitation, Anxiety, Confusional State, Dizziness, Encephalopathy, Peripheral Motor Neuropathy, Peripheral Sensory Neuropathy, Speech Disorder
on Aug 21, 2010 Female patient from UNITED STATES , child 12 years of age, weighting 105.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, anxiety (What is anxiety?), confusional state, dizziness (What is dizziness?), encephalopathy, peripheral motor neuropathy, peripheral sensory neuropathy, speech disorder. Sprycel dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6937761-3 | Alopecia, Bronchopneumonia, Contusion, Decreased Appetite, Depression, Dizziness, Dry Skin, Fibromyalgia
Patient was taking Sprycel (View Usage). Patient had the following side effects: alopecia, bronchopneumonia, contusion, decreased appetite, depression (What is depression?), dizziness (What is dizziness?), dry skin, fibromyalgia on Aug 18, 2010 from SPAIN Additional patient health information: Female patient , 62 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: 50mg Alter 100mg Int 18dc07 Re 24jan08 Rein 25ag08 Re 27nv08(50mg/d) Re 16ar(50 Al 100mg). Patient was hospitalized.

6936108-6 | Abdominal Pain Upper, Liver Function Test Abnormal, Nausea
Adverse event was reported on Aug 19, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: 50 Mg Bid Po) was diagnosed with neoplasm malignant and. Location: UNITED STATES , weighting 167.1 lb, After Sprycel was administered, patient had the following side effects: abdominal pain upper, liver function test abnormal, nausea (What is nausea?). During the same period patient was treated with GEMZAR (1810mg D 1, 8, 15 Iv) (View Gemzar Review and Gemzar Label ). Patient was hospitalized.

6931994-8 | Acute Respiratory Failure
on Aug 17, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure. Sprycel dosage: . During the same period patient was treated with FINASTERIDE (View Finasteride Review and Finasteride Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), FLOMAX (View Flomax Review and Flomax Label ), NIACIN (View Niacin Review and Niacin Label ), AMBIEN (View Ambien Review and Ambien Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6931085-6 | Acne
on Aug 17, 2010 Male patient from UNITED STATES , 54 years of age, was diagnosed with myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: acne (What is acne?). Sprycel dosage: Take 1 Po.

6929289-1 | C-reactive Protein Increased, Diarrhoea, Enteritis Infectious, Gastrointestinal Haemorrhage, Pyrexia
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: c-reactive protein increased, diarrhoea, enteritis infectious, gastrointestinal haemorrhage, pyrexia on Aug 16, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, weighting 119.0 lb, was diagnosed with acute lymphocytic leukaemia, prophylaxis, infection prophylaxis, antiviral prophylaxis, upper respiratory tract inflammation and. Sprycel dosage: 2dec09-29jan10:50x2mg/d 09feb10-ong:20x1mg/d. During the same period patient was treated with METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (3 Df-3tabs) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), L CARBOCISTEINE (View L-carbocisteine Review and L-carbocisteine Label ), CYPROHEPTADINE HCL (View Cyproheptadine Hcl Review and Cyproheptadine Hcl Label ). Patient was hospitalized.

6928739-4 | Ascites, Hepatomegaly, Pleural Effusion, Pulmonary Arterial Hypertension, Respiratory Acidosis, Weight Increased
Adverse event was reported on Aug 13, 2010 by a Male patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia, asthma (What is asthma?) and. Location: FRANCE , 37 years of age, Patient experienced the following unwanted or unexpected effects: ascites, hepatomegaly, pleural effusion, pulmonary arterial hypertension, respiratory acidosis, weight increased. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), SYMBICORT (Turbuhaler) (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

6928551-6 | Anaemia, Cardio-respiratory Arrest, Encephalopathy, Febrile Neutropenia, Neutrophil Count Decreased, Oedema Peripheral, Platelet Count Decreased, Pleural Effusion
on Aug 13, 2010 Female patient from JAPAN , 69 years of age, weighting 97.00 lb, was diagnosed with chronic myeloid leukaemia, prophylaxis and was treated with Sprycel (View Usage). Patient had the following side effects: anaemia, cardio-respiratory arrest, encephalopathy, febrile neutropenia, neutrophil count decreased, oedema peripheral, platelet count decreased, pleural effusion. Sprycel dosage: . During the same period patient was treated with NILOTINIB (Capsule) (View Nilotinib Review and Nilotinib Label ), NIZATIDINE (Tab) (View Nizatidine Review and Nizatidine Label ), ITRACONAZOLE (Solution) (View Itraconazole Review and Itraconazole Label ), COTRIM (1 Df: 2 Tab;formulation :tab) (View Cotrim Review and Cotrim Label ), MYSLEE (Tab) (View Myslee Review and Myslee Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EPINEPHRINE (Formulation-inj;1 Df: 3a/day) (View Epinephrine Review and Epinephrine Label ). Patient was hospitalized.

6927748-9 | Abdominal Pain, Blood Albumin Decreased, Blood Glucose Increased, Diarrhoea, Dizziness, Hypocalcaemia, Hyponatraemia, Hypophosphataemia, Hypotension
on Jul 21, 2010 Female patient from UNITED STATES , child 12 years of age, was diagnosed with b precursor type acute leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), blood albumin decreased, blood glucose increased, diarrhoea, dizziness (What is dizziness?), hypocalcaemia, hyponatraemia, hypophosphataemia, hypotension. Sprycel dosage: 1540 Milligram Total Oral. During the same period patient was treated with DAUNORUBICIN HCL (188 Milligram Total Iv) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), PEG L ASPARAGINASE (PEGASPARGASE) (4750 International Unit Total Im) (View Peg-l-asparaginase (pegaspargase) Review and Peg-l-asparaginase (pegaspargase) Label ), PREDNISONE (2484 Milligram Total Oral) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (8 Milligram Iv) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6925975-8 | Anaemia, Full Blood Count Decreased, Hypokalaemia, Malignant Neoplasm Progression, Mouth Haemorrhage, Pancytopenia, Pneumonia, Pyrexia
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, full blood count decreased, hypokalaemia, malignant neoplasm progression, mouth haemorrhage, pancytopenia, pneumonia (What is pneumonia?), pyrexia on Aug 10, 2010 from JAPAN Additional patient health information: Male patient , 35 years of age, weighting 154.3 lb, was diagnosed with blast crisis in myelogenous leukaemia, adverse event and. Sprycel dosage: Interrupted On 20may09 + Restarted On 27may09 100 Mg Daily, 100mg/day, 27may09/28jul09. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), POTASSIUM CHLORIDE (Tabs) (View Potassium Chloride Review and Potassium Chloride Label ). Patient was hospitalized.

6918914-7 | Diarrhoea, Leukopenia, Ulcer
Adverse event was reported on Aug 09, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: Dose Reduced To 100mg In One Take(oral)) was diagnosed with chronic myeloid leukaemia and. Location: ARGENTINA , 37 years of age, Patient had the following side effects: diarrhoea, leukopenia, ulcer (What is ulcer?).

6918890-7 | Agitation, Anxiety, Confusional State, Dizziness, Encephalopathy, Peripheral Motor Neuropathy, Peripheral Sensory Neuropathy, Speech Disorder
on Aug 05, 2010 Female patient from UNITED STATES , child 12 years of age, weighting 105.8 lb, was diagnosed with acute lymphocytic leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: agitation, anxiety (What is anxiety?), confusional state, dizziness (What is dizziness?), encephalopathy, peripheral motor neuropathy, peripheral sensory neuropathy, speech disorder. Sprycel dosage: Last Dose On 8jan10 Dose 60mg/m2 Po Qd Delayed For 10 Days On Days 1-14, 22-35, 43-56. During the same period patient was treated with CYTARABINE (Delayed For 10 Dys Lst Dose On 31dec09) (View Cytarabine Review and Cytarabine Label ), HYDROCORTISONE (Last Dose On 31dec09 Delayed For 10 Days) (View Hydrocortisone Review and Hydrocortisone Label ), METHOTREXATE (20mg/m2 Qd On Days8,15,22,29,36,43+50 Last Dose 15 Mg It On 31dec09 Delayed For 10 Days) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6915620-X | Dehydration, Gastrointestinal Haemorrhage
on Aug 03, 2010 Female patient from UNITED STATES , child 4 years of age, weighting 33.07 lb, was diagnosed with b precursor type acute leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, gastrointestinal haemorrhage. Sprycel dosage: Last Dose On 12jul2010.no Of Courses:3. During the same period patient was treated with CYTARABINE (Last Dose On 05jul2010.no Of Courses:3) (View Cytarabine Review and Cytarabine Label ), METHOTREXATE (Last Dose On 03jul2010.no Of Courses:3) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6913890-5 | C-reactive Protein Increased, Diarrhoea, Enteritis Infectious, Gastrointestinal Haemorrhage, Haematochezia, Pyrexia
Patient was taking Sprycel (View Usage). Patient had the following side effects: c-reactive protein increased, diarrhoea, enteritis infectious, gastrointestinal haemorrhage, haematochezia, pyrexia on Aug 04, 2010 from JAPAN Additional patient health information: Male patient , 78 years of age, weighting 119.0 lb, was diagnosed with acute lymphocytic leukaemia, prophylaxis, infection prophylaxis, antiviral prophylaxis, upper respiratory tract inflammation and. Sprycel dosage: 2dec09-29jan10:50x2mg/d 09feb10-ong:20x1mg/d. During the same period patient was treated with METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (3 Df-3tabs) (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), L CARBOCISTEINE (View L-carbocisteine Review and L-carbocisteine Label ), CYPROHEPTADINE HCL (View Cyproheptadine Hcl Review and Cyproheptadine Hcl Label ). Patient was hospitalized.

6909034-6 | Anaemia, Cardio-respiratory Arrest, Encephalopathy, Febrile Neutropenia, Neutrophil Count Decreased, Oedema Peripheral, Platelet Count Decreased, Pleural Effusion
Adverse event was reported on Aug 02, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with chronic myeloid leukaemia, prophylaxis and. Location: JAPAN , 69 years of age, weighting 97.00 lb, After Sprycel was administered, patient had the following side effects: anaemia, cardio-respiratory arrest, encephalopathy, febrile neutropenia, neutrophil count decreased, oedema peripheral, platelet count decreased, pleural effusion. During the same period patient was treated with NILOTINIB (Capsule) (View Nilotinib Review and Nilotinib Label ), NIZATIDINE (Tab) (View Nizatidine Review and Nizatidine Label ), ITRACONAZOLE (Solution) (View Itraconazole Review and Itraconazole Label ), COTRIM (1 Df: 2 Tab;formulation :tab) (View Cotrim Review and Cotrim Label ), MYSLEE (Tab) (View Myslee Review and Myslee Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), EPINEPHRINE (Formulation-inj;1 Df: 3a/day) (View Epinephrine Review and Epinephrine Label ). Patient was hospitalized.

6905664-6 | Atrial Fibrillation, Weight Increased
on Jul 29, 2010 Female patient from FRANCE , 72 years of age, was diagnosed with chronic myeloid leukaemia, arrhythmia (What is arrhythmia?) and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), weight increased. Sprycel dosage: Decided To Reintroduce At 50mg Per Day. During the same period patient was treated with FLECAINIDE ACETATE (Flecaine 150mg Lp) (View Flecainide Acetate Review and Flecainide Acetate Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), LASIX (View Lasix Review and Lasix Label ).

6905636-1 | Lymphadenopathy
on Aug 02, 2010 Male patient from SPAIN , 35 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: lymphadenopathy. Sprycel dosage: .

6895620-9 |
Patient was taking Sprycel (View Usage). on Jul 28, 2010 from COLOMBIA Additional patient health information: Male patient , 40 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: . During the same period patient was treated with TASIGNA (View Tasigna Review and Tasigna Label ).

6887017-2 | Abortion Spontaneous, Pregnancy
Adverse event was reported on Jul 22, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: ) was diagnosed with leukaemia and. Location: BRAZIL , 30 years of age, Patient experienced the following unwanted or unexpected effects: abortion spontaneous, pregnancy (What is pregnancy?).

6886999-2 | Abortion Spontaneous, Pregnancy
on Jul 22, 2010 Female patient from BRAZIL , 30 years of age, was diagnosed with leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: abortion spontaneous, pregnancy (What is pregnancy?). Sprycel dosage: .

6883601-0 |
on Jul 23, 2010 Female patient from PERU , 13 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). . Sprycel dosage: .

6883582-X | Fungal Infection, Pneumonia, Respiratory Failure
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: fungal infection (What is fungal infection?), pneumonia (What is pneumonia?), respiratory failure on Jul 23, 2010 from ITALY Additional patient health information: Male patient , 72 years of age, was diagnosed with chronic myeloid leukaemia, platelet aggregation inhibition, hyperuricaemia, hypertension, hypothyroidism and. Sprycel dosage: . During the same period patient was treated with ASPIRIN (Str 100 Mg) (View Aspirin Review and Aspirin Label ), ALLOPURINOL (50 Mg Tabs) (View Allopurinol Review and Allopurinol Label ), DILATREND (6.25 Tabs.) (View Dilatrend Review and Dilatrend Label ), EUTIROX (View Eutirox Review and Eutirox Label ).

6882295-8 | Diarrhoea, Hypocalcaemia, Hyponatraemia, Hypotension
Adverse event was reported on Jul 21, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: Course:1) was diagnosed with b precursor type acute leukaemia and. Location: UNITED STATES , child 12 years of age, weighting 158.7 lb, Patient had the following side effects: diarrhoea, hypocalcaemia, hyponatraemia, hypotension. During the same period patient was treated with DAUNORUBICIN HCL (Course:1) (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), ONCASPAR (Course:1) (View Oncaspar Review and Oncaspar Label ), PREDNISONE (13apr-19apr10,624mg Course:1) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (Course:1) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

6882281-8 | Carbon Monoxide Diffusing Capacity Decreased, Interstitial Lung Disease, Pleural Effusion
on Jul 21, 2010 Female patient from UNITED STATES , 66 years of age, weighting 125.7 lb, was diagnosed with breast cancer metastatic and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: carbon monoxide diffusing capacity decreased, interstitial lung disease, pleural effusion. Sprycel dosage: 70mg Qd. During the same period patient was treated with BEVACIZUMAB (5mg/kg Q 2 Wks) (View Bevacizumab Review and Bevacizumab Label ). Patient was hospitalized.

6880210-4 | Pruritus
on May 27, 2010 Male patient from UNITED STATES , 73 years of age, was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus. Sprycel dosage: .

6880204-9 | Diarrhoea, Pain, Palpitations, Vomiting
Patient was taking Sprycel (View Usage). Patient had the following side effects: diarrhoea, pain (What is pain?), palpitations, vomiting on May 18, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 180.8 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: 1st Dose: 12may2010(evening);2nd Dose: 13may2010.. During the same period patient was treated with PRILOSEC (View Prilosec Review and Prilosec Label ).

6880198-6 | Hypersensitivity, Malignant Neoplasm Progression
Adverse event was reported on May 06, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: ) . Location: UNITED STATES , 74 years of age, After Sprycel was administered, patient had the following side effects: hypersensitivity, malignant neoplasm progression.

6880192-5 | Dyspnoea
on Apr 21, 2010 Female patient from UNITED STATES , 35 years of age, was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea. Sprycel dosage: . During the same period patient was treated with TASIGNA (View Tasigna Review and Tasigna Label ).

6880189-5 | Pancytopenia
on Apr 20, 2010 Female patient from UNITED STATES , 27 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: pancytopenia. Sprycel dosage: Reduced To 50mg/d.

6880184-6 | Headache
Patient was taking Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: headache (What is headache?) on Apr 06, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, weighting 200.6 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: 4 Yrs Ago.

6880180-9 | Effusion, Fluid Retention, Pleural Effusion, Pneumonia
Adverse event was reported on Mar 31, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: 100mg In Nov2009 Restarted On 05-jan-2010, At 50mg And Now Taking 70mg) was diagnosed with chronic myeloid leukaemia and. Location: UNITED STATES , 58 years of age, weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: effusion, fluid retention, pleural effusion, pneumonia (What is pneumonia?). During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLYBURIDE (1 Df = 5mg In The Am And 2.5mg In The Pm) (View Glyburide Review and Glyburide Label ), DIOVAN (View Diovan Review and Diovan Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), LASIX (1 Df = 40mg In The Am And 20mg In Pm) (View Lasix Review and Lasix Label ), POTASSIUM (View Potassium Review and Potassium Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

6880179-2 | Breast Mass, Decreased Appetite, Diplopia, Disturbance In Attention, Memory Impairment, Nipple Pain
on Mar 29, 2010 Male patient from UNITED STATES , 63 years of age, weighting 189.6 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient had the following side effects: breast mass, decreased appetite, diplopia, disturbance in attention, memory impairment, nipple pain. Sprycel dosage: . During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ), ZYLOPRIM (View Zyloprim Review and Zyloprim Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ).

6880178-0 | Urinary Tract Infection
on Mar 29, 2010 Female patient from UNITED STATES , 54 years of age, weighting 235.9 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: urinary tract infection (What is urinary tract infection?). Sprycel dosage: . During the same period patient was treated with ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), SINGULAIR (View Singulair Review and Singulair Label ).

6880175-5 | Pleural Effusion
Patient was taking Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: pleural effusion on Mar 24, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: 1df-70 Units Not Mentioned,100mg Also Given.

6880166-4 | Gait Disturbance, Muscle Tightness
Adverse event was reported on Mar 08, 2010 by a Female patient taking Sprycel (View Usage) (Dosage: ) . Location: UNITED STATES , 67 years of age, Patient had the following side effects: gait disturbance, muscle tightness.

6880161-5 | Dry Eye, Eye Pain
on Mar 04, 2010 Female patient from UNITED STATES , 75 years of age, weighting 163.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). After Sprycel was administered, patient had the following side effects: dry eye, eye pain. Sprycel dosage: 2df- 2 Tabs Hs. During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ).

6880160-3 | Electrocardiogram Qt Prolonged
on Mar 25, 2010 Male patient from UNITED STATES , 75 years of age, weighting 273.4 lb, was diagnosed with chronic myeloid leukaemia and was treated with Sprycel (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged. Sprycel dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), COMBIVENT (View Combivent Review and Combivent Label ), IRON TABLETS (View Iron Tablets Review and Iron Tablets Label ), LASIX (View Lasix Review and Lasix Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), POTASSIUM (View Potassium Review and Potassium Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6880157-3 | Arrhythmia, Chest Discomfort, Dyspnoea
Patient was taking Sprycel (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), chest discomfort, dyspnoea on Apr 02, 2010 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 149.9 lb, was diagnosed with chronic myeloid leukaemia and. Sprycel dosage: .